Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent.
Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent.
复制标题
DOI:
10.1016/j.apradiso.2009.08.013
复制
发表时间:
2010-01
影响因子:
1.6
通讯作者:
Packard, Alan B.
中科院分区:
文献类型:
--
作者:
Heinrich, Tobias K.;Gottumukkala, Vijay;Snay, Erin;Dunning, Patricia;Fahey, Frederic H.;Treves, S. Ted;Packard, Alan B.
There is considerable interest in developing an 18F-labeled PET myocardial perfusion agent. Rhodamine dyes share several properties with 99mTc-MIBI, the most commonly used single-photon myocardial perfusion agent, suggesting that an 18F-labeled rhodamine dye might prove useful for this application. In addition to being lipophilic cations, like 99mTc-MIBI, rhodamine dyes are known to accumulate in the myocardium and are substrates for Pgp, the protein implicated in MDR1 multidrug resistance. As the first step in determining whether 18F-labeled rhodamines might be useful as myocardial perfusion agents for PET, our objective was to develop synthetic methods for preparing the 18F-labeled compounds so that they could be evaluated in vivo. Rhodamine B was chosen as the prototype compound for development of the synthesis because the ethyl substituents on the amine moieties of rhodamine B protect them from side reactions, thus eliminating the need to include (and subsequently remove) protecting groups. The 2′-[18F]fluoroethyl ester of rhodamine B was synthesized by heating rhodamine B lactone with [18F]fluoroethyltosylate in acetonitrile at 165°C for 30 min.using [18F]fluoroethyl tosylate, which was prepared by the reaction of ethyleneglycol ditosylate with Kryptofix 2.2.2, K2CO3, and [18F]NaF in acetonitrile for 10 min. at 90°C. The product was purified by semi-preparative HPLC to produce the 2′-[18F]-fluoroethylester in >97% radiochemical purity with a specific activity of 1.3 GBq/μmol, an isolated decay corrected yield of 35%, and a total synthesis time of 90 min.
登录
查看更多内容
DOI:
10.1007/s002590050403
发表时间:
1999-04-01
期刊:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
影响因子:
--
作者:
De Moerloose, B;Van de Wiele, C;Dierckx, RA
通讯作者:
Dierckx, RA
影响因子:
3.1
作者:
VORA, MM;DHALLA, M
通讯作者:
DHALLA, M
影响因子:
9.3
作者:
Madar, Igal;Ravert, Hayden;Becker, Lewis
通讯作者:
Becker, Lewis
影响因子:
2.4
作者:
Wallhaus, TR;Lacy, J;Stone, CK
通讯作者:
Stone, CK
影响因子:
3.1
作者:
Yoon, YH;Jeong, JM;Lee, MC
通讯作者:
Lee, MC